Remyelination

December 30, 2015December 30, 2015

NIH Grant to Advance Multiple Sclerosis Therapy Targeting Remyelination

News

Novoron Bioscience, Inc., a biotech company focused on developing therapies for disorders of the central nervous system, recently announced that it has received a $680,000 National ... Read more

December 29, 2015

Read the Top 10 Multiple Sclerosis Articles of 2015

10 – “Vaccine Against MS Being Developed at Baylor Institute for Immunology Research” Read full article here: http://bit.ly/1R5z9xd Read Top 10 Multiple Sclerosis Articles of 2015: http://bit.ly/1MD9gia ... Read more

December 28, 2015December 28, 2015

Top 10 Multiple Sclerosis Articles of 2015

News

Multiple Sclerosis News Today has reported the latest therapies, clinical trial developments, and events in multiple sclerosis (MS) on a daily basis throughout the past year. ... Read more

December 10, 2015December 10, 2015

In Multiple Sclerosis Study, Vitamin D Shown to Aid Myelin Repair

News

A new study in the Journal of Cell Biology suggests that vitamin D activates a receptor involved in myelin regeneration in patients with multiple sclerosis (MS). The study, ... Read more

November 23, 2015

Last Week’s Top-3 Most Read Posts On Multiple Sclerosis

Read the Articles Here:   Myelin Dysfunction in MS and Other White Matter Diseases Found to Be Linked to Specific Gene Mutations Could Remyelination Be Achieved ... Read more

November 20, 2015November 20, 2015

MS Society Funds 5 Projects Aiming to Cure the Disease

News

The Multiple Sclerosis Society (MS Society) in the United Kingdom recently announced the investment of £1.98 million in new MS research. After an in-depth, rigorous review ... Read more

November 16, 2015

Last Week’s Top-3 Most Read Posts On Multiple Sclerosis

Read the Articles Here: Novartis’ MS Drug Gilenya Prevents Activation of Key Immune Cells in Study Multiple Sclerosis Pilot Study Evaluating PoNS Yields Promising Results Could ... Read more

November 13, 2015November 13, 2015

Could Remyelination Be Achieved in MS Using an Anti-Inflammatory Treatment?

Multiple Sclerosis News, News

In a recent study entitled “Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination,” researchers investigated whether sulfasalazine treatment, an anti-inflammatory and immune-modulating drug, ... Read more

September 7, 2015September 12, 2016

New Study Unravels How Myelin is Repaired, May Suggest New MS Treatments

Multiple Sclerosis News, News

Japanese scientists have discovered new information about how the myelin sheath is repaired following damage. Myelin is a fatty substance that wraps around nerve cells and helps ... Read more

September 3, 2015October 21, 2016

Biomarkers of Early MS and Overactive Bladder Identified in New Study

Multiple Sclerosis News, News

Researchers at the University of Athens Medical School in Greece have found that people with early stage multiple sclerosis (MS) and overactive bladder (OAB) have reductions in brain serotonin and ... Read more

August 6, 2015August 10, 2015

Could Salt Intake be an MS Risk Factor?

Multiple Sclerosis News, News

Most people know that eating too much salt is bad for your health, but a new study suggests that it could also increase the risk for ... Read more

July 16, 2015July 16, 2015

Study Shows Skin Problems Can Be Caused by Interferon-β MS Therapy

Multiple Sclerosis News, News

Skin problems may be caused by interferon-β, a common treatment for multiple sclerosis (MS), according to a new study published by a German research group at ... Read more

July 14, 2015July 14, 2015

Nano-Drugs in Liposomes Could Treat Multiple Sclerosis

Multiple Sclerosis News, News

Nano-drugs encased in liposomes could one day be used to treat neurological diseases like multiple sclerosis (MS), according to a new study published July 6th in ... Read more

May 12, 2015May 12, 2015

Researchers Identify Drugs That Promote Remyelination in Mice

Multiple Sclerosis News, News

In a recent publication in Nature, titled “Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo” a team of researchers from Case Western University and Northwestern ... Read more

May 7, 2015May 7, 2015

Myelin Repair Foundation and NIH to Study Guanabenz for MS

Multiple Sclerosis News, News

The Myelin Repair Foundation (MRF) and National Institutes of Health (NIH) will initiate a clinical trial of guanabenz in people with multiple sclerosis (MS). Guanabenz is FDA-approved for high ... Read more

May 1, 2015May 1, 2015

Genzyme’s LEMTRADA Maintain’s Effectiveness in Reducing Brain Atrophy According to Recent Study Results

Multiple Sclerosis News, News

Genzyme presented new magnetic resonance imaging (MRI) data from the Lemtrada® (alemtuzumab) clinical development program on April 23, 2015, at the 67th American Academy of Neurology (AAN) Annual Meeting. The ... Read more

April 29, 2015April 29, 2015

Can Suppressing a Protein Associated With Good Health Help Treat MS?

Multiple Sclerosis News, News

Gladstone Institutes scientists have discovered a successful new treatment that could potentially be used in multiple sclerosis (MS). The treatment involves suppressing a protein that traditionally is ... Read more

April 23, 2015April 23, 2015

Phase III Study of Experimental MS Therapy Meets Primary Endpoint, Results to be Presented at ANN Meeting

Multiple Sclerosis News, News

MedDay, a French biotechnology company that studies treatments for nervous system disorders, including multiple sclerosis, announced that MD1003, a highly-concentrated biotin, is effective for treatment of progressive ... Read more

April 22, 2015April 22, 2015

Two Already-Approved Medications Could Treat MS

Multiple Sclerosis News, News

Two already available medications could be used to treat multiple sclerosis (MS). In a new study titled, “Drug Based Modulation of Endogenous Stem Cells,” published in the journal Nature on ... Read more

April 16, 2015April 18, 2015

Co-existing MS and FM Influences Pain Threshold, According to New Study

Multiple Sclerosis News, News

People with multiple sclerosis (MS) commonly experience a low pain threshold and sensitivity to heat and cold. If a person has multiple sclerosis along with fibromyalgia ... Read more

April 13, 2015October 20, 2015

Biogen to Focus on RRMS Disease Management, Treatment at Upcoming Conference

Multiple Sclerosis News, News

Biogen plans to present new clinical data at the 67th American Academy of Neurology (AAN) Annual Meeting in Washington D.C., April 18 – 25, 2015, including numerous ... Read more

November 19, 2014April 13, 2016

Experimental Multiple Sclerosis Drug Effectively Induces Remyelination in Pre-clinical Study

Multiple Sclerosis News, News

In a poster session at the Annual meeting of the Society for Neuroscience in Washington, ENDECE Neural presented pre-clinical results showing their lead drug – NDC-1308 – ... Read more

September 3, 2014September 3, 2014

Researchers Advance New Stem Cell Methods for Remyelination in MS Patients

Multiple Sclerosis News, News

In-vitro laboratory experiments using stem cells have long-since been the subject of debate between scientists and naturalists, but when it comes to developing effective methods to ... Read more

July 9, 2014July 10, 2014

Antihistamine Repurposed for Remyelination in Phase 2 Trial from UCSF

Multiple Sclerosis News, News

The University of California, San Francisco (UCSF) initiated a clinical trial to evaluate the antihistamine clemastine fumarate, manufactured by Novartis as Tavist, for its efficacy in ... Read more

June 25, 2014June 26, 2014

Roche Turns to MS Research on Agreement with Versant Ventures

Multiple Sclerosis News, News

The Swiss pharmaceutical company Roche recently announced a partnership agreement with California-based Inception Sciences and venture capital firm Versant Ventures. The three companies will work together to form ... Read more

June 19, 2014July 19, 2016

Remyelination Strategies for Multiple Sclerosis Presented at Biogen Idec-Sponsored NYAS Conference

Multiple Sclerosis News, News

On June 26th, a conference devoted to the topic of “Demyelination and Remyelination: From Mechanism to Therapy” will be presented by the New York Academy of ... Read more